Summary
Zoetis Inc. (ZTS) reported its financial results for the period ending June 29, 2019, as filed in its 10-Q/A. While the provided excerpt is brief and focuses on exhibits, an investor would typically look for key financial performance indicators, revenue growth drivers, profitability trends, and strategic updates in a full 10-Q filing. Investors should pay close attention to the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section to understand the company's performance drivers and outlook. Furthermore, any significant legal or regulatory matters disclosed would be crucial for risk assessment.
Financial Highlights
53 data pointsBeta
Financial Statements
Beta
| Revenue | $1.55B |
| Cost of Revenue | $465.00M |
| Gross Profit | $1.08B |
| SG&A Expenses | $406.00M |
| Operating Expenses | $1.07B |
| Interest Expense | $55.00M |
| Net Income | $371.00M |
| EPS (Basic) | $0.77 |
| EPS (Diluted) | $0.77 |
| Shares Outstanding (Basic) | 478.80M |
| Shares Outstanding (Diluted) | 482.30M |
Key Highlights
- 1The filing is an amendment (10-Q/A), suggesting potential revisions or additions to a previously filed report.
- 2The reporting period concludes on June 29, 2019.
- 3The filing date was August 8, 2019.
- 4Key exhibits, such as CEO certifications (Exhibit 31.1), are listed, indicating compliance with financial reporting standards.
- 5Investors should examine the full 10-Q for detailed financial statements and management commentary.
- 6The company's operational and financial performance for the second quarter of 2019 would be the primary focus for investors.
- 7Understanding any reasons for the amendment to the 10-Q would be important.
Frequently Asked Questions
The provided excerpt does not contain specific financial results. A full review of the 10-Q filing is necessary to ascertain revenue, net income, earnings per share, and other key financial metrics.
An amendment to a 10-Q filing typically indicates that the company is making corrections, additions, or providing updated information to its previously submitted quarterly report. The specific reasons for the amendment would be detailed within the filing itself, often in an introductory section or by highlighting the changes made.
The excerpt does not provide details on revenue drivers. Investors should refer to the 'Management's Discussion and Analysis' section of the full 10-Q filing to understand the company's performance by product line, geographic region, and any new product launches or market trends contributing to growth.
The provided text only lists exhibits. A comprehensive review of the full 10-Q report, particularly the 'Risk Factors' and 'Management's Discussion and Analysis' sections, is required to identify any material risks or uncertainties facing Zoetis.